what semaglutides are approved for weight loss Zepbound vs Semaglutide GLP-1 vs Wegovy: What's the Difference Tirzepatide vs Semaglutide: What You

We, therefore, focused on reviewing all notes not included in our manual review pool that had inconsistent outputs across exemplar runs

Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist two mechanisms working together, which is why head-to-head data shows tirzepatide producing roughly 20% body weight loss at 72 weeks versus semaglutide's roughly 15%

However, studies show that approximately 6070% of people regain significant weight within 12 months after stopping, making long-term maintenance therapy a practical choice for many

The magnitude depends on your baseline glucose level, kidney function, and concurrent medications

10.1111/dme.12328 10 BornerT.GeislerC

Take home message You can safely take Wegovy if you dont have a gallbladder